EVIO Inc. to Change OTCQB Ticker Symbol to ”EVIO”

BEND, OR / ACCESSWIRE / October 2, 2017 / EVIO, Inc. (OTCQB: SGBYD) (”EVIO” or the ”Company”) the nation’s leading provider of analytical laboratory cannabis testing, research science and advisory services, is proud to announce the change of its OTCQB ticker symbol from SGBYD to EVIO has been approved by FINRA, effective open of trading on October 3, 2017.

”Our new ticker symbol is now aligned with our corporate name and further reinforces our brand as EVIO Labs,” said William Waldrop, Chief Executive Officer. ”We have now completed our corporate alignment for both customer and shareholders alike, this change helps us simplify our messaging to all of our stakeholders.”

No action is needed from EVIO’s current shareholders in relation to the ticker symbol change. The common stock will continue to be listed on the OTCQB and the CUSIP will remain unchanged as 30051V106.

To subscribe to company updates: investors@eviolabs.com.

About EVIO

EVIO, Inc. is a life science company that provides accredited analytical testing services and scientific research to the regulated cannabis industry. The Company’s EVIO Labs division operating coast-to-coast provides state-mandated ancillary services in place to ensure the safety and quality of the nation’s cannabis supply. Learn more at www.eviolabs.com.

1-888-544-EVIO

Safe Harbor Statement

Any statements in this press release that are not statements of historical fact maybe considered to be forward-looking statements. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Words such as ”may,” ”will,” ”expect,” ”believe,” ”anticipate,” ”estimate,” ”intends,” ”goal,” ”objective,” ”seek,” ”attempt,” or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or www.eviolabs.com.

CONTACT:

William Waldrop
CEO
EVIO, Inc. (OTCQB: SGBYD)
702-343-7470

SOURCE: EVIO, Inc.

ReleaseID: 476878